AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24727022
Drug: MK-5172 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-5172 (400 mg) and (800 mg) with peginterferon and ribavirin
Trial: 22952407
Drug: Local anaesthetic
RxNorm normalized name: Local anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anaesthetic (Bupivicaine) and steroid (Trimacinolone) injection (n=18)
Trial: 21564061
Drug: Both therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both therapy process modalities
Trial: 21564061
Drug: Enactment-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enactment-based therapy process
Trial: 17073160
Drug: Herceptin therapy
RxNorm normalized name: Herceptin
DrugBank: Trastuzumab (DB00072)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Herceptin therapy
Trial: 1547763
Drug: CBZ-CR 800
RxNorm normalized name: CBZ
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBZ-CR 800 mg
Trial: 1547763
Drug: CBZ-CR 1200
RxNorm normalized name: CBZ
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBZ-CR 1200 mg
Trial: 1547763
Drug: CBZ-CR 1600
RxNorm normalized name: CBZ
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBZ-CR 1600 mg
Trial: 1547763
Drug: CBZ-CR (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBZ-CR (all doses)
Trial: 1547763
Drug: CBZ-CR 800
RxNorm normalized name: CBZ
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBZ-CR 800 mg, 1200 mg, 1600 mg
Trial: 25893979
Drug: Topical ketoprofen
RxNorm normalized name: ketoprofen Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketoprofen in Transfersome(®) gel (IDEA‐033) plus oral placebo
Trial: 25893979
Drug: Oral ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ketoprofen plus TDT 064
Trial: 25893979
Drug: TDT 064
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TDT 064 plus oral placebo
Trial: 19968904
Drug: First-generation statin
RxNorm normalized name: First-generation cephalosporins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation statin cholesterol-lowering medication
Trial: 18667204
Drug: EPA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA treatment (n=7503)
Trial: 14738263
Drug: Gemcitabine 1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1250 mg/m2 on day 1 and day 8 and Cisplatin 80 mg/m2 on day 1, administered every 3 weeks, followed by radiotherapy after chemotherapy.
Trial: 9184183
Drug: Oral etoposide
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral etoposide phosphate 125 mg m(‐2) on days 1‐5 every 3 weeks, escalating to 175 mg m(‐2) from course 3 when possible
Trial: 3891194
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride preparation 1
Trial: 3891194
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride preparation 2
Trial: 24222839
Drug: Intravenous ivabradine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ivabradine (5 mg bolus over 30 s, followed by 5 mg infusion over 8 h)
Trial: 30115103
Drug: Intravenous ivabradine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ivabradine
Trial: 7682007
Drug: Psychopharmacological medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychopharmacological medication (withdrawn)
Trial: 4036935
Drug: Aspirin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (3 x 325 mg tablets)
Trial: 4036935
Drug: Ibuprofen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (1 x 600 mg tablet)
Trial: 4036935
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 identical placebo tablets)
Trial: 30898632
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate cream (GTN)
Trial: 25724645
Drug: S-ketamine 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-ketamine 0.25 mg/kg orally
Trial: 25724645
Drug: S-ketamine 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-ketamine 0.125 mg/kg intravenously
Trial: 23245993
Drug: Short-acting β(2)-agonists
RxNorm normalized name: Short-acting sulfonamides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-acting β(2)-agonists (SABA)
Trial: 23245993
Drug: Muscarinic antagonists
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Muscarinic antagonists (SAMA)
Trial: 14688498
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
Trial: 1385603
Drug: ondansetron (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron (4 mg)
Trial: 19468545
Drug: droperidol (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: droperidol (1.25 mg)
Trial: 19468545
Drug: metoclopramide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide (10 mg)
Trial: 9133308
Drug: Thrombolysis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolysis with streptokinase 1.5 million IU plus oral aspirin 150 mg OD (n = 12)
Trial: 6852623
Drug: D-penicillamine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-penicillamine (600 mg/day)
Trial: 6852623
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (5 mg/day)
Trial: 6852623
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment after D-penicillamine or medroxyprogesterone
Trial: 27189284
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg subcutaneous dose
Trial: 24589307
Drug: Intraperitoneal infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal infusion of catumaxomab after complete resection of all macroscopic disease.
Trial: 24589307
Drug: Intraperitoneal infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal infusion of catumaxomab with different total doses administered in each of the 2 arms.
Trial: 21546443
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate (10 mg elemental zinc)
Trial: 19057412
Drug: Fluoxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine treatment for 12 weeks
Trial: 17948207
Drug: Conventional weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional weight loss treatment
Trial: 17948207
Drug: Obese individuals
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Obese individuals not participating in weight loss treatment
Trial: 30799396
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral prednisolone for 3 days (PSL 3)
Trial: 30799396
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral prednisolone for 7 days (PSL 7)
Trial: 30799396
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral prednisolone (both groups)
Trial: 26013187
Drug: febuxostat 80
RxNorm normalized name: febuxostat 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: febuxostat 80 mg/day
Trial: 26013187
Drug: febuxostat 40
RxNorm normalized name: febuxostat 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: febuxostat 40 mg/day
Trial: 26013187
Drug: allopurinol 300
RxNorm normalized name: allopurinol 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: allopurinol 300 mg/day
Trial: 25411289
Drug: VA+ (white
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VA+ (white maize with 400 μg retinol activity equivalents in oil)
Trial: 22464779
Drug: LAM +
RxNorm normalized name: lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LAM + ADV combination therapy
Trial: 22464779
Drug: LAM mono-therapy
RxNorm normalized name: tiotropium bromide mono
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAM mono-therapy
Trial: 22464779
Drug: ADV mono-therapy
RxNorm normalized name: tiotropium bromide mono
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADV mono-therapy
Trial: 19387976
Drug: Time-delayed capsule
RxNorm normalized name: ascorbic acid Oral Capsule [C-Time]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time-delayed capsule formulation with 20% HPMC
Trial: 19387976
Drug: Time-delayed capsule
RxNorm normalized name: ascorbic acid Oral Capsule [C-Time]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time-delayed capsule formulation with 24% HPMC
Trial: 19387976
Drug: Time-delayed capsule
RxNorm normalized name: ascorbic acid Oral Capsule [C-Time]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time-delayed capsule formulation with 35% HPMC
Trial: 19387976
Drug: Nondisintegrating riboflavin
RxNorm normalized name: Riboflavin
DrugBank: Riboflavin (DB00140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nondisintegrating riboflavin tablet (used in pulsed release study)
Trial: 15330916
Drug: Duodenal bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duodenal bolus infusions of 5 ml of acid
Trial: 15330916
Drug: Duodenal bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duodenal bolus infusions of normal saline
Trial: 15330916
Drug: Ondansetron (5‐HT(3)
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron (5‐HT(3) receptor antagonist)
Trial: 1607978
Drug: Epidural corticosteroids
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural corticosteroids (40 mg methylprednisolone acetate)
Trial: 28689524
Drug: Supervised Structured
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised Structured Aerobic Exercise Training (SSAET) program, routine medication, and dietary plan
Trial: 29171557
Drug: Routine medication
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine medication and dietary plan
Trial: 18773134
Drug: Vaginal vault
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal vault suspension after hysterectomy (n = 32)
Trial: 12950574
Drug: 2% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% chlorhexidine gel (CG), coronally unsealed
Trial: 12950574
Drug: Calcium hydroxide
RxNorm normalized name: Calcium Hydroxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium hydroxide + 2% chlorhexidine gel (CaOH2 + CG), coronally unsealed
Trial: 12950574
Drug: 2% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% chlorhexidine gel (CG) + coronal seal
Trial: 12950574
Drug: Calcium hydroxide
RxNorm normalized name: Calcium Hydroxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium hydroxide + 2% chlorhexidine gel (CG + CaOH2) + coronal seal
Trial: 12950574
Drug: Positive control
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive control group (PC) - no treatment, coronally unsealed
Trial: 8723171
Drug: Pranidipine 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranidipine 1 mg od
Trial: 8723171
Drug: Pranidipine 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranidipine 2 mg od
Trial: 8723171
Drug: Pranidipine 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranidipine 4 mg od
Trial: 8723171
Drug: Pranidipine 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranidipine 8 mg od
Trial: 1362887
Drug: L-659,066 (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-659,066 (8 mg administered by short intravenous infusion)
Trial: 3907286
Drug: Oral anticoagulants
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulants for one month
Trial: 10874063
Drug: Oral anticoagulants
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulants for six months
Trial: 27676396
Drug: 0 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/d CAP from chili powder
Trial: 27676396
Drug: 5 mg/d
RxNorm normalized name: Arixtra 5 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/d CAP from chili powder
Trial: 27676396
Drug: 10 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/d CAP from chili powder
Trial: 12425363
Drug: Botulinum toxin-A
RxNorm normalized name: Botulinum toxin A
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Botulinum toxin-A (btA) injection with conventional physical therapy
Trial: 8610920
Drug: Breast cancer
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast cancer treatment in black women
Trial: 1356277
Drug: Alpidem (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem (mean dose 112.5 mg daily)
Trial: 1356277
Drug: Lorazepam (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (mean 3.5 mg daily)
Trial: 3895962
Drug: Single-dose treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose treatment with 500 mg clotrimazole vaginal tablet
Trial: 3895962
Drug: 3-day treatment
RxNorm normalized name: Gyne-Lotrimin 2% 3-Day Treatment Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day treatment with two 100 mg vaginal tablets administered daily
Trial: 20497921
Drug: Standard support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard support therapy (ST)
Trial: 16178478
Drug: Glucose-only-based solutions
RxNorm normalized name: glucose Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-only-based solutions
Trial: 12546607
Drug: Diclofenac sodium,
RxNorm normalized name: diclofenac sodium, micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac sodium, 75 mg twice daily
Trial: 12546607
Drug: Acetaminophen, 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen, 1000 mg 4 times daily
Trial: 7561223
Drug: 8-hourly administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8-hourly administration of controlled-release morphine (MS Contin)
Trial: 7561223
Drug: 12-hourly administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-hourly administration of controlled-release morphine (MS Contin)
Trial: 7561223
Drug: 8-hourly and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-hourly and 12-hourly administration of controlled-release morphine (MS Contin)
Trial: 1782724
Drug: Control (unchanged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (unchanged EPO prescription)
Trial: 31611496
Drug: Acidic solution,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acidic solution, pH 1-2 (CS)
Trial: 31611496
Drug: Alkaline solution,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alkaline solution, pH 10-11 (KS)
Trial: 28597306
Drug: Etanercept-methotrexate combination
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept-methotrexate combination therapy
Trial: 28597306
Drug: Placebo-methotrexate combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo-methotrexate combination therapy
Trial: 21424238
Drug: Topical steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroids (prednisolone 0.5%)
Trial: 21424238
Drug: Prophylactic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic treatment duration
Trial: 19894007
Drug: Pulsed signal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed signal therapy
Trial: 17362810
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg once daily for 7 days
Trial: 17362810
Drug: Amoxicillin/clavulanate 500/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 500/125 mg 3 times daily for 10 days
Trial: 11210396
Drug: NN703 (growth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NN703 (growth hormone secretagogue) administered po as a solution, dose levels: 8, with 6 subjects on active treatment per dose level.
Trial: 11210396
Drug: Placebo (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (control group), 2 subjects per dose level.
Trial: 9553909
Drug: Low-dose etretinate
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose etretinate therapy
Trial: 31834814
Drug: Daily running
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily running exercise for 7 days
Trial: 31379058
Drug: Tenofovir or
RxNorm normalized name: emtricitabine/nelfinavir/tenofovir oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir or adefovir treatment for 4 years
Trial: 27851857
Drug: Eravacycline, 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eravacycline, 1.0 mg/kg every 12 hours for a minimum of four 24-hour dosing cycles
Trial: 27851857
Drug: Ertapenem, 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertapenem, 1.0 g every 24 hours for a minimum of four 24-hour dosing cycles
Trial: 25611803
Drug: Mometasone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mometasone (400 μg)
Trial: 25611803
Drug: Mometasone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mometasone (400 μg) administered 30 min before albuterol
Trial: 25611803
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered 30 min before albuterol
Trial: 25739188
Drug: Remaxol (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remaxol (intravenous drip, 400 ml per day, 10 days)
Trial: 25739188
Drug: Essentiale N
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essentiale N (intravenous bolus, 5 ml per day, 10 days)
Trial: 17585221
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg etanercept intradiscally
Trial: 17585221
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg etanercept intradiscally
Trial: 17585221
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg etanercept intradiscally
Trial: 17585221
Drug: 0.75 mg
RxNorm normalized name: propinox 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg etanercept intradiscally
Trial: 17585221
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg etanercept intradiscally
Trial: 17585221
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg etanercept intradiscally
Trial: 9704955
Drug: PolyHeme (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PolyHeme (up to 6 U, 300 g)
Trial: 25738481
Drug: ACEI-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEI-based treatment (enalapril)
Trial: 25738481
Drug: Diuretic-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic-based treatment (hydrochlorothiazide)
Trial: 21198801
Drug: Standard injection
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard injection technique (not changing the needle)
Trial: 16433809
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate 0.05% in thermophobic foam (CF) applied twice daily
Trial: 9051539
Drug: Oral-transdermal clonidine
RxNorm normalized name: clonidine Transdermal System
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral-transdermal clonidine regimen (4 to 5 mu/kg oral clonidine and 0.2 mg/24 hours transdermal patch)
Trial: 9051539
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet and patch
Trial: 9051539
Drug: Oral-transdermal clonidine
RxNorm normalized name: clonidine Transdermal System
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral-transdermal clonidine regimen